E.R. Squibb & Sons, L.L.C. Recalls

Bristol-Myers Squibb Recalls Opdualag Injection Over Sterility Issue

Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.